Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study

DSpace Repository

Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study

Author: Blonde, Lawrence; Rosenstock, Julio; Frias, Juan; Birkenfeld, Andreas L.; Niemoeller, Elisabeth; Souhami, Elisabeth; Ji, Chen; Del Prato, Stefano; Aroda, Vanita R.
Tübinger Autor(en):
Birkenfeld, Andreas L.
Published in: Diabetes Care (2021), Bd. 44, H. 3, S. 774-780
Verlagsangabe: Amer Diabetes Assoc
Language: English
Full text: http://dx.doi.org/10.2337/dc20-2023
ISSN: 1935-5548
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)